MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Exagen P/S Ratio 2011-2026 | XGN
Annual P/S Ratio Exagen
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.596 | 0.885 | 2.51 | 4.73 | 1.99 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 4.73 | 0.596 | 2.14 |
P/S Ratio of other stocks in the Diagnostics research industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
1.72 | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
0.1 | - | -17.87 % | $ 25.9 M |  Canada |
 |
BioNano Genomics
BNGO
|
0.115 | $ 1.12 | -0.88 % | $ 1.42 M |  USA |
 |
Brainsway Ltd.
BWAY
|
8.09 | $ 24.41 | 1.2 % | $ 99.4 M |  Israel |
 |
Burning Rock Biotech Limited
BNR
|
6.87 | $ 27.63 | -4.06 % | $ 297 M |  China |
 |
Aspira Women's Health
AWH
|
5.55 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
13.5 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
0.229 | - | -13.05 % | $ 7.29 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
5.71 | - | - | $ 562 M |  Britain |
 |
Danaher Corporation
DHR
|
6.09 | $ 209.19 | - | $ 149 B | USA |
 |
DarioHealth Corp.
DRIO
|
2.13 | $ 11.26 | - | $ 319 M | Israel |
 |
Chembio Diagnostics
CEMI
|
0.254 | - | 0.22 % | $ 16.8 M | USA |
 |
Enzo Biochem
ENZ
|
0.0018 | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
1.65 | $ 23.09 | 0.35 % | $ 698 M | USA |
 |
Co-Diagnostics
CODX
|
5.13 | - | - | $ 79.8 M | USA |
 |
Global Cord Blood Corporation
CO
|
0.196 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
3.48 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
1.36 K | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
2.9 | - | 0.12 % | $ 80.1 M | China |
 |
Quest Diagnostics Incorporated
DGX
|
1.93 | $ 209.54 | - | $ 23.3 B | USA |
 |
Castle Biosciences
CSTL
|
2.14 | $ 29.94 | 3.46 % | $ 832 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
2.47 | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
1.86 | $ 19.25 | 2.45 % | $ 1.03 B | USA |
 |
DermTech
DMTK
|
2.77 | - | -11.32 % | $ 2.94 M | USA |
 |
DexCom
DXCM
|
5.47 | $ 73.09 | -0.23 % | $ 28.5 B | USA |
 |
Interpace Biosciences
IDXG
|
0.0879 | $ 1.74 | -5.95 % | $ 7.63 M | USA |
 |
Exact Sciences Corporation
EXAS
|
6 | $ 103.45 | 0.06 % | $ 19.5 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.71 | $ 287.13 | 0.64 % | $ 23.9 B | USA |
 |
Guardant Health
GH
|
13.7 | $ 95.4 | 1.04 % | $ 12 B | USA |
 |
QIAGEN N.V.
QGEN
|
5.03 | - | - | $ 10.6 B |  Niderland |
 |
Charles River Laboratories International
CRL
|
1.92 | $ 166.06 | - | $ 8.23 B | USA |
 |
Myriad Genetics
MYGN
|
0.496 | $ 4.43 | 1.14 % | $ 410 M | USA |
 |
Heska Corporation
HSKA
|
3.28 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
0.469 | - | -20.0 % | $ 1.06 M | USA |
 |
ICON Public Limited Company
ICLR
|
3.25 | $ 104.09 | -0.54 % | $ 8.59 B |  Irlanda |
 |
ENDRA Life Sciences
NDRA
|
1.59 K | $ 3.86 | 2.93 % | $ 2.07 M | USA |
 |
IDEXX Laboratories
IDXX
|
11.9 | $ 649.23 | 4.19 % | $ 52.2 B | USA |
 |
Illumina
ILMN
|
3.75 | $ 122.9 | 1.96 % | $ 19.5 B | USA |
 |
Natera
NTRA
|
6.47 | $ 209.53 | 0.09 % | $ 20.6 B | USA |
 |
IQVIA Holdings
IQV
|
1.74 | $ 164.88 | - | $ 28.3 B | USA |
 |
Motus GI Holdings
MOTS
|
3.1 | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
7.06 | $ 1 379.66 | - | $ 28.4 B |  Schweiz |
|
Biodesix
BDSX
|
1.29 | $ 13.02 | 1.96 % | $ 1.69 B | USA |
 |
Quidel Corporation
QDEL
|
6.36 | $ 21.93 | 3.49 % | $ 924 M | USA |
 |
Pacific Biosciences of California
PACB
|
7.05 | $ 1.66 | 5.06 % | $ 421 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
1.8 | $ 31.5 | 0.9 % | $ 20 B | Niderland |
 |
Lantheus Holdings
LNTH
|
4.21 | $ 73.61 | 0.26 % | $ 5.09 B | USA |
 |
Biomerica
BMRA
|
1.35 | $ 2.1 | - | $ 4.82 M | USA |